Skip to main content
. 2018 Jul 26;13(7):e0201420. doi: 10.1371/journal.pone.0201420

Table 3. Descriptives for Hao Hao’s (SB741) 2016 reproductive cycle: USpG-, creatinine-corrected and raw metabolite concentration, USpG-values and creatinine concentrations in urine and faecal output.

Pro-oestrus
(D-8 -D0)
Postoestrus
(D0—D6)
Primary P4 rise
(D7—D76)
Secondary P4 rise
(D77-D114)
Post Birth
(D119-D125)
Mean (stdev) Median (range) Mean (stdev) Median (range) Mean (stdev) Median (range) Mean (stdev) Median (range) Mean (stdev) Median (range)
Oestrogens (n = 28/28) (n = 17/17) (n = 64/65) (n = 49/49) (n = 5/5)
USpG (ng/mL) 83.41 (61.31) 63.03 (31.61–306.5)b 27.46 (24.87) 16.86 (2.62–88.82)a 2.67 (1.19) 2.42 (0.85–6.80)a 6.61 (3.62) 5.82 (1.31–14.89)a 2.43 (1.86) 1.66 (0.50–5.29)a
Creatinine (ng/mg Cr) 94.60 (55.13) 80.71 (36.36–249.1)c 41.83 (47.51) 20.36 (3.57–189.7)b 12.87 (33.76) 6.63 (2.10–272.7)a,b 8.07 (4.60) 7.32 (2.88–30.46)a,b 2.10 (0.81) 1.84 (1.12–3.18)a
Raw (ng/ mL) 84.18 (71.06) 75.49 (16.33–391.0)b 31.67 (26.96) 21.48 (1.56–77.49)a 1.99 (1.01) 1.85 (0.46–4.82)a 10.07 (8.71) 6.72 (0.76–35.46)a 6.89 (6.93) 4.49 (0.54–18.14)a
Progesterone (n = 28/28) (n = 17/17) (n = 64/65) (n = 49/49) (n = 5/5)
USpG (ng/mL) 3.00 (1.22) 2.60 (1.63–7.27)a 6.85 (2.78) 5.90 (3.40–13.27)a 14.39 (6.28) 13.90 (5.69–37.54)a 87.30 (43.85) 86.40 (26.60–174.9)b 6.22 (2.89) 5.21 (3.80–10.99)a
Creatinine (ng/mg Cr) 3.48 (1.04) 3.21 (2.10–5.75)a 12.67 (15.20) 7.32 (4.94–67.26)a 62.63 (127.5) 32.43 (3.54–999.8)a,b 129.83 (88.75) 117.61 (19.87–372.9)b 6.27 (1.40) 5.76 (4.83–8.51)a
Raw (ng/ mL) 2.95 (1.30) 2.83 (0.71–6.81)a 8.88 (7.02) 6.12 (0.61–29.00)a 9.77 (4.61) 8.58 (0.92–18.94)a 112.16 (74.17) 93.30 (14.39–334.6)b 16.26 (13.01) 11.77 (4.11–37.64)a
Ceruloplasmin (n = 28/28) (n = 17/17) (n = 64/65) (n = 49/49) (n = 5/5)
USpG (ng/mL) 6.50 (3.51) 5.44 (1.73–15.55)b,c 4.49 (2.62) 4.69 (0.73–8.79)a,b 10.18 (3.98) 9.96 (2.44–19.18)c 4.60 (3.49) 3.63 (0.61–18.01)a,b 0.71 (0.30) 0.82 (0.19–0.91)a
Creatinine (ng/mg Cr) 7.51 (3.97) 6.87 (2.24–22.22)a,b 12.72 (2.62) 6.84 (0.47–98.47)a,b 35.26 (35.21) 29.19 (9.07–280.0)b 10.45 (14.89) 3.96 (0.49–56.72)a,b 0.85 (0.70) 0.68 (0.21–2.04)a
Raw (ng/ mL) 6.28 (3.50) 5.49 (2.03–14.02)b 4.75 (3.16) 3.23 (0.90–11.34)a,b 7.69 (4.32) 6.41 (2.73–20.42)b 4.59 (2.33) 4.34 (1.20–12.47)a,b 1.71 (1.06) 1.93 (0.35–3.06)a
PGFM (n = 28/28) (n = 17/17) (n = 29/65) (n = 49/49) (n = 5/5)
USpG (ng/mL) 14.03 (8.52) 12.38 (2.51–34.82)a 15.52 (11.34) 14.47 (3.10–52.40)a 2.75 (1.02) 2.72 (1.21–6.34)a 119.58 (254.71) 26.64 (2.07–1344)a 40.76 (25.98) 33.37 (9.52–76.92)a
Creatinine (ng/mg Cr) 17.54 (12.38) 13.44 (3.71–46.06)a 24.03 (17.73) 18.66 (7.07–66.55)a 10.02 (8.43) 7.11 (2.98–45.12)a 92.87 (171.48) 24.96 (5.99–857.3)a 36.34 (10.68) 36.87 (20.77–46.16)a
Raw (ng/ mL) 13.70 (9.30) 11.43 (2.71–39.95)a 24.50 (34.69) 19.18 (0.61–151.2)a 2.12 (1.26) 1.70 (0.81–5.61)a 281.53 (767.56) 38.61 (1.23–4605)a 112.18 (98.34) 77.35 (10.03–263.6)a
USpG (n = 28/28) (n = 17/17) (n = 65/65) (n = 49/49) (n = 5/5)
USpG 1.006 (0.003) 1.006 (1.002–1.011)a,b 1.007 (0.004) 1.007 (1.001–1.016)b 1.004 (0.002) 1.004 (1.002–1.012)a 1.007 (0.004) 1.007 (1.002–1.019)b 1.013 (0.005) 1.015 (1.006–1.019)
Cr (n = 28/28) (n = 17/17) (n = 64/65) (n = 49/49) (n = 5/5)
Creatinine (mg/mL) 0.90 (0.44) 0.85 (0.26–1.92)a,b 1.19 (1.10) 0.92 (0.09–4.24)b,c 0.29 (0.18) 0.26 (0.01–0.82)a 1.52 (1.34) 1.07 (0.09–5.37)c 2.70 (1.97) 2.44 (0.48–5.71)
Faeces (n = 6/28) (n = 4/17) (n = 61/65) (n = 44/49)
Faeces (kg) 4.97 (1.09) 4.85 (3.70–6.60)a 8.53 (2.48) 9.30 (5.00–10.50)a,b 12.64 (4.31) 14.00 (3.70–22.00)b 5.47 (6.38) 2.80 (1.00–23.20)a

Stdev = standard deviation; n = number of samples; USpG = urinary specific gravity; cr = creatinine.

a-c = different superscripts (a-c; ascending; horizontally) indicate significant differences for the respective metabolite levels between each defined reproductive period; Independent-Samples Kruskall Wallis test with post hoc Dunn’s comparison; significant if p < 0.05.